Acelyrin (SLRN) Earnings Date, Estimates & Call Transcripts $2.27 0.00 (0.00%) As of 05/21/2025 Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Acelyrin Earnings Summary Acelyrin issued Q1 2025 earnings on May 14, 2025, reporting an EPS of -$0.55, which topped analysts' consensus estimates of -$0.95 by $0.40. With a trailing EPS of -$2.69, Acelyrin's earnings are expected to grow next year, from ($2.53) to ($2.19) per share. Upcoming Q2 Earnings DateAug. 12After Market ClosesEstimatedConsensus EPS (May. 14) -$0.95 Actual EPS (May. 14) -$0.55 Beat By $0.40 Q1 2025 Earnings ResourcesQ1 2025 Earnings Report Quarterly Report (10-Q) Press Release (8-K)SLRN Upcoming EarningsAcelyrin's next earnings date is estimated for Tuesday, August 12, 2025, based on past reporting schedules. Powered by Get Acelyrin Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Acelyrin and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataSLRN Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Acelyrin Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.44-$0.44-$0.44Q2 20251-$0.46-$0.46-$0.46Q3 20251-$0.49-$0.49-$0.49Q4 20251-$0.52-$0.52-$0.52 Acelyrin Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/12/2025(Estimated)--------5/14/2025Q1 2025-$0.95-$0.55+$0.40-$0.55--3/19/2025Q4 2024-$0.86-$0.79+$0.07-$0.79--8/13/2024Q2 2024-$0.78-$0.86 -$0.08-$0.86--5/14/2024Q1 2024-$0.93-$0.36+$0.57-$0.36--3/28/2024Q4 2023-$1.00-$0.75+$0.25-$0.75--11/7/2023Q3 2023-$0.47-$0.87 -$0.40-$0.87--8/14/2023Q2 2023-$0.81-$0.56+$0.25-$0.72-- Acelyrin Earnings - Frequently Asked Questions When is Acelyrin's earnings date? Acelyrin has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 12th, 2025 based off last year's report dates. Learn more on SLRN's earnings history. Did Acelyrin beat their earnings estimates last quarter? In the previous quarter, Acelyrin (NASDAQ:SLRN) reported ($0.55) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.95) by $0.40. Learn more on analysts' earnings estimate vs. SLRN's actual earnings. How much profit does Acelyrin generate each year? Acelyrin (NASDAQ:SLRN) has a recorded net income of -$381.64 million. SLRN has generated -$2.69 earnings per share over the last four quarters. What is Acelyrin's EPS forecast for next year? Acelyrin's earnings are expected to grow from ($2.53) per share to ($2.19) per share in the next year. More Earnings Resources from MarketBeat Related Companies RCUS Earnings Results SYRE Earnings Results AVDL Earnings Results MLYS Earnings Results NRIX Earnings Results ZYME Earnings Results AVBP Earnings Results PRAX Earnings Results ARDX Earnings Results LENZ Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Smith & Wesson Stock Falls on Earnings Miss, Tariff WoesWhat to Expect From the Q2 Earnings Reporting CycleBroadcom Slides on Solid Earnings, AI Outlook Still StrongFive Below Pops on Strong Earnings, But Rally May StallRed Robin's Comeback: Q1 Earnings Spark Investor HopesOllie’s Q1 Earnings: The Good, the Bad, and What’s NextBroadcom Earnings Preview: AVGO Stock Near Record Highs This page (NASDAQ:SLRN) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredGold: Now legal tender in many statesThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | Sponsored“E.I.”- The biggest prediction of my career?One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acelyrin, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Acelyrin With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
